glp 1 high heart rate What GLP-1s are Really Doing to Your Training Why Does GLP-1 Increase Heart

MyNetDiary MyNetDiary combines in-depth nutrition tracking with focused GLP-1 support, offering a well-rounded platform for users managing their weight and medication

A protein shake or small meal can support recovery without requiring you to force down food when your appetite is suppressed

63 SIRT6 is a gene that encodes a member of the sirtuin family of NAD-dependent enzymes that are implicated in cellular stress resistance, genomic stability, aging, and energy homeostasis

Discover more insights in the video and read the full article on Minuti website #FondazioneMenarini Pregnancy management - Minuti Science 269 To view or add a comment, sign in Pregnancy heightens periodontal risk, yet education and timely nonsurgical therapy can improve outcomes

Nat Commun 10 , 924 (2019)

The Core GLP-1 Mechanism GLP-1 Pathway Simplified Meal Intake Intestinal L-cells release GLP-1 GLP-1 binds GLP-1 receptors cAMP signaling Activation of PKA + PI3K/Akt pathways Multiple metabolic benefits Practical Clinical Effects In the Pancreas Insulin secretion from -cells Glucagon secretion from -cells Preservation of -cell mass Reduced -cell apoptosis In the Brain Appetite suppression Satiety enhancement Reduced food cravings In the Gastrointestinal Tract Delayed gastric emptying Reduced postprandial glucose spikes In Peripheral Tissues Improved glucose uptake Enhanced insulin sensitivity Reduced hepatic gluconeogenesis Evolution of GLP-1 Therapy: Historical Milestones Current Era Emergence of: Oral GLP-1 drugs Dual agonists Triple agonists Small-molecule GLP-1 therapies Current GLP-1 Agents Short-Acting Exenatide Lixisenatide Long Acting Liraglutide Dulaglutide Semaglutide Oral GLP-1 Oral semaglutide Orforglipron (new generation oral small-molecule GLP-1RA) Dual Agonists Tirzepatide (GLP-1 + GIP) Triple Agonists Retatrutide (GLP-1 + GIP + glucagon receptor) These newer agents are redefining obesity medicine and cardiometabolic care